Bifogade filer
PDF
Kurs & Likviditet
Kalender
| 2023-08-09 | Kvartalsrapport 2023-Q2 |
| 2023-06-15 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2023-06-14 | Årsstämma 2023 |
| 2023-03-22 | Bokslutskommuniké 2022 |
| 2022-08-10 | Kvartalsrapport 2022-Q2 |
| 2022-06-16 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2022-06-15 | Årsstämma 2022 |
| 2022-03-09 | Extra Bolagsstämma 2022 |
| 2022-02-16 | Bokslutskommuniké 2021 |
| 2021-08-11 | Kvartalsrapport 2021-Q2 |
| 2021-04-22 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2021-04-21 | Årsstämma 2021 |
| 2021-02-17 | Bokslutskommuniké 2020 |
| 2020-08-12 | Kvartalsrapport 2020-Q2 |
| 2020-04-23 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2020-04-22 | Årsstämma 2020 |
| 2020-02-19 | Bokslutskommuniké 2019 |
| 2019-08-14 | Kvartalsrapport 2019-Q2 |
| 2019-04-25 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2019-04-24 | Årsstämma 2019 |
| 2019-02-20 | Bokslutskommuniké 2018 |
| 2018-08-22 | Kvartalsrapport 2018-Q2 |
| 2018-08-16 | Extra Bolagsstämma 2018 |
| 2018-04-26 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2018-04-25 | Årsstämma 2018 |
| 2018-02-28 | Bokslutskommuniké 2017 |
| 2017-07-27 | Kvartalsrapport 2017-Q2 |
| 2017-04-27 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2017-04-26 | Årsstämma 2017 |
| 2017-02-02 | Bokslutskommuniké 2016 |
| 2016-10-20 | 15-10 2016-Q3 |
| 2016-08-10 | Kvartalsrapport 2016-Q2 |
| 2016-05-12 | Kvartalsrapport 2016-Q1 |
| 2016-04-26 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2016-04-25 | Årsstämma 2016 |
| 2016-02-25 | Bokslutskommuniké 2015 |
| 2015-10-22 | Kvartalsrapport 2015-Q3 |
| 2015-08-20 | Kvartalsrapport 2015-Q2 |
| 2015-05-07 | Kvartalsrapport 2015-Q1 |
| 2015-04-21 | Ordinarie utdelning BIOBV 0.00 EUR |
| 2015-04-20 | Årsstämma 2015 |
| 2015-02-26 | Bokslutskommuniké 2014 |
| 2014-10-23 | Kvartalsrapport 2014-Q3 |
| 2014-08-21 | Kvartalsrapport 2014-Q2 |
| 2014-05-08 | Kvartalsrapport 2014-Q1 |
| 2014-04-15 | Ordinarie utdelning BIOBV 0.72 EUR |
| 2014-04-14 | Årsstämma 2014 |
| 2014-02-27 | Bokslutskommuniké 2013 |
| 2013-10-24 | Kvartalsrapport 2013-Q3 |
| 2013-08-08 | Kvartalsrapport 2013-Q2 |
| 2013-04-25 | Kvartalsrapport 2013-Q1 |
| 2013-04-09 | Ordinarie utdelning BIOBV 0.50 EUR |
| 2013-04-08 | Årsstämma 2013 |
| 2013-02-27 | Bokslutskommuniké 2012 |
| 2012-10-25 | Kvartalsrapport 2012-Q3 |
| 2012-08-16 | Kvartalsrapport 2012-Q2 |
| 2012-04-26 | Kvartalsrapport 2012-Q1 |
| 2012-04-12 | Ordinarie utdelning BIOBV 1.00 EUR |
| 2012-04-11 | Årsstämma 2012 |
| 2012-02-29 | Bokslutskommuniké 2011 |
| 2011-11-23 | Extra Bolagsstämma 2011 |
| 2011-10-20 | Kvartalsrapport 2011-Q3 |
| 2011-08-18 | Kvartalsrapport 2011-Q2 |
| 2011-04-14 | Ordinarie utdelning |
| 2010-04-26 | Ordinarie utdelning |
| 2009-04-21 | Ordinarie utdelning |
| 2008-04-22 | Ordinarie utdelning |
| 2007-04-20 | Ordinarie utdelning |
| 2006-04-21 | Ordinarie utdelning |
| 2005-04-22 | Ordinarie utdelning |
| 2004-04-16 | Ordinarie utdelning |
| 2003-04-10 | Ordinarie utdelning |
| 2002-04-02 | Ordinarie utdelning |
| 2001-03-28 | Ordinarie utdelning |
| 2000-04-07 | Ordinarie utdelning |
| 1999-04-22 | Ordinarie utdelning |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Small Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Publishing on August 22, 2022 at 13:30 am local time (EEST)
Head of Technical Product Management Panu Hendolin, PhD, has been appointed member of the Management Team of Biohit Oyj starting September 1, 2022. Hendolin is responsible for innovation and life cycle management of the medical devices. Hendolin reports to CEO Päivi Siltala.
Hendolin has worked at Biohit as R&D and Production Director in 2007-2008, as well as 2012-2017, and he returned to the company in February 2022. In the meanwhile, Hendolin worked as Production Director at United Medix Laboratories Oy and Chief Technology Officer at Sulapac Oy. Hendolin has the degree of Ph.D. in molecular medicine.
Additional information:
Päivi Siltala, CEO, Biohit Oyj, tel. +358 50460 9510
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is "Innovating for Health" - we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group.www.biohithealthcare.com (https://www.globenewswire.com/Tracker?data=ciyb_iZ945H2z3sK3a9i7Zs03Nkj9jr5Brw7kC1tsoUye5PVgko06PC57Z9BVVT2pXUgp6sn-tswLd2MUgQOQc8UNXD2BkNm3L02XzRJ7XfJCPaPUqGS1mpI0NZinK5T)